Totals
- Total revenue
- $349,805
- Total expenses
- $99,457
- Contributions and grants received
- $345,308
- Grants paid
- $53,750
- Program service revenue
- $0
- Investment income
- $4,497
- Other revenue
- $0
- Total assets, end of year
- $652,708
- Total liabilities, end of year
- $0
- Net assets or fund balances, end of year
- $652,708
- Program services expenses (Part IX)
- $94,929
- Management and general expenses
- $4,528
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $94,929
Program services were 95.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$345,308
-
3 · Investment income
total $4,497 · excluded $4,497
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $31,250 · program services $31,250
-
3 · Grants to foreign organizations and individuals
total $22,500 · program services $22,500
-
11g · Fees: other
total $30,740 · program services $28,940 · management and general $1,800
-
12 · Advertising and promotion
total $10,306 · program services $10,306
-
13 · Office expenses
total $2,727 · management and general $2,727
-
24a · Other expenses: MEALS & ENTERTAINMENT E
total $1,845 · program services $1,845
-
24b · Other expenses: SUPPLIES EXP.
total $88 · program services $88
-
24c · Other expenses: BANK FEES
total $1 · management and general $1
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $402,360 · end of year $8,211
-
11 · Investments: publicly traded securities
end of year $644,497
-
27 · Net assets without donor restrictions
beginning of year $402,360 · end of year $652,708
Mission and programs · 2023
Mission
JACK'S TOMORROW INC. MISSION IS TO FUND RESEARCH TO DEVELOP A TREATMENT AND ULTIMATELY A CURE FOR PURA SYNDROME.
Activities or mission (Part I)
FUND RESEARCH TO DEVELOP A TREATMENT AND ULTIMATELY A CURE FOR PURA SYNDROME
-
THE ORGANIZATION IS CURRENTLY WORKING WITH SEVERAL RESEARCH GROUPS ON VARIOUS PROJECTS TO UNDERSTAND THE FUNCTIONING OF THE PURA GENE AND POTENTIAL THERAPEUTIC APPROACHES.
Expenses $94,929 · Grants $53,750
As filed on the 2023 return.
Listed in Part VII
-
Jean WeinbergJEAN WEINBERG
CO-FOUNDER & PRESIDENT
- Total calculated
- $0
- Hours/week
- 10
-
Kyle CzepielKYLE CZEPIEL
CO-FOUNDER & DIRECTOR
- Total calculated
- $0
- Hours/week
- 12
-
Raph PosnerRAPH POSNER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
-
Adam CaponADAM CAPON
DIRECTOR
- Total calculated
- $0
- Hours/week
- 2
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
$31,250
FUNDING A 2 YEAR RESEARCH PROGRAM ON THE PURA GENE - GOAL TO DEVELOP A CURE FOR PURA SYNDROME.
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 15 November 2024
- IRS schema version
- 2023v5.1
- Source object
- 202443209349327234
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.